RIGL - Latest News

Rigel Pharmaceuticals, Inc. (RIGL), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $837.2M. Trailing twelve-month P/E ratio is 2.71. Beta to the broader market is 1.24.

The article list below shows the most recent RIGL headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent RIGL Headlines

Rigel Pharmaceuticals: Top-Line Momentum Meets Margin Compression In Q3

seekingalpha.com - Nov 10, 2026

Rigel Pharmaceuticals shows strong top-line growth but faces margin compression, with Q3 revenues up 16. 5% year-over-year and net income down 52.

Rigel to Present at the Jefferies Global Healthcare Conference in London

prnewswire.com - Nov 10, 2026

SOUTH SAN FRANCISCO, Calif. , Nov.

Rigel Pharmaceuticals Q3 Earnings Call Highlights

marketbeat.com - Nov 6, 2026

Rigel Pharmaceuticals NASDAQ: RIGL reported record quarterly product sales in the third quarter of 2026, helped by the launch of breast cancer treatme

Rigel Pharmaceuticals, Inc. (RIGL) Q3 2026 Earnings Call Transcript

seekingalpha.com - Nov 6, 2026

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals (RIGL) Misses Q3 Earnings Estimates

zacks.com - Nov 6, 2026

Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0. 65 per share, missing the Zacks Consensus Estimate of $0.

How News Affects RIGL Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track RIGL's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked RIGL news questions

What is the latest RIGL news headline?
The most recent RIGL headline (Nov 10, 2026) is "Rigel Pharmaceuticals: Top-Line Momentum Meets Margin Compression In Q3". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the RIGL news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What RIGL news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual RIGL options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.